191 related articles for article (PubMed ID: 37665172)
1. Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.
Chen WH; Axell-House DB
J Med Virol; 2023 Sep; 95(9):e29078. PubMed ID: 37665172
[TBL] [Abstract][Full Text] [Related]
2. A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.
Moore C; Marcucci V; Torres P; Liu E; Parker GS
Am J Case Rep; 2023 Sep; 24():e940177. PubMed ID: 37660250
[TBL] [Abstract][Full Text] [Related]
3. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Mazzotta V; Cozzi-Lepri A; Lanini S; Mondi A; Carletti F; Tavelli A; Gagliardini R; Vita S; Pinnetti C; Aguglia C; Colavita F; Faccendini P; Matusali G; Faraglia F; Beccacece A; Paulicelli J; Girardi E; Nicastri E; Vaia F; Maggi F; Antinori A
J Med Virol; 2023 Jun; 95(6):e28868. PubMed ID: 37306318
[TBL] [Abstract][Full Text] [Related]
4. Mpox in the New York metropolitan area, Summer 2022.
Gnanaprakasam R; Keller M; Glassman R; El-Khoury MY; Chen DS; Feola N; Feldman J; Chaturvedi V
J Med Virol; 2023 Apr; 95(4):e28699. PubMed ID: 36951318
[TBL] [Abstract][Full Text] [Related]
5. Severe soft tissue infection: A complication of mpox in an individual with HIV coinfection requiring vaccinia intravenous immunoglobulin and intravenous tecovirimat.
Mahtani AU; Seelam H; Padda I; Mahmoud M; D Cuomo J; Khalil BW; Haider M; Khalil A; Elemam A; Nfonoyim J
J Med Virol; 2023 Jul; 95(7):e28917. PubMed ID: 37394761
[TBL] [Abstract][Full Text] [Related]
6. Tecovirimat for the treatment of severe Mpox in Germany.
Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
Contag CA; Mische L; Fong I; Karan A; Vaidya A; McCormick DW; Bower W; Hacker JK; Johnson K; SanJuan P; Crebbin L; Temmins C; Sahni H; Bogler Y; Cooper JD; Narasimhan S
Emerg Infect Dis; 2023 Dec; 29(12):2520-2523. PubMed ID: 37856215
[TBL] [Abstract][Full Text] [Related]
8. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
[TBL] [Abstract][Full Text] [Related]
9. Treatment with tecovirimat of the first two cases of monkeypox in Japan.
Inada M; Saito S; Tsuzuki S; Okumura N; Sato L; Kamegai K; Sanada M; Komatsubara M; Shimojima M; Ebihara H; Kasuya F; Nagashima M; Sadamasu K; Yamamoto K; Ujiie M; Morioka S; Ohmagari N
J Infect Chemother; 2023 Apr; 29(4):418-421. PubMed ID: 36690208
[TBL] [Abstract][Full Text] [Related]
10. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
[TBL] [Abstract][Full Text] [Related]
11. Early use of tecovirimat in a young man with severe mpox skin lesions: a case report.
Iannone V; Ciccullo A; Farinacci D; Borghetti A; Visconti E; Marchetti S; Sanguinetti M; Tamburrini E; Di Giambenedetto S
J Med Virol; 2023 Feb; 95(2):e28528. PubMed ID: 36695663
[No Abstract] [Full Text] [Related]
12. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
[TBL] [Abstract][Full Text] [Related]
13. A Case of Neonatal Monkeypox Treated With Oral Tecovirimat.
Castejon-Ramirez S; Pennington J; Beene H; Hysmith N; Ost S
Pediatrics; 2024 Jan; 153(1):. PubMed ID: 38148743
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
15. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
16. The use of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS.
Thet AK; Kelly PJ; Kasule SN; Shah AK; Chawala A; Latif A; Chilimuri SS; Zeana CB
Clin Infect Dis; 2023 May; 76(9):1671-1673. PubMed ID: 36571287
[TBL] [Abstract][Full Text] [Related]
17. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome.
Viguier C; de Kermel T; Boumaza X; Benmedjahed NS; Izopet J; Pasquier C; Delobel P; Mansuy JM; Martin-Blondel G
Int J Infect Dis; 2022 Dec; 125():135-137. PubMed ID: 36397606
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat.
Nunes DDS; Higa LM; Oliveira RL; da Costa LC; Bomfim LM; Gonçalves CCA; Mariani D; Hruby DE; Voloch CM; Castiñeiras TMPP; Tanuri A; Damaso CR
Mem Inst Oswaldo Cruz; 2023; 118():e230056. PubMed ID: 37436275
[TBL] [Abstract][Full Text] [Related]
19. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
O'Laughlin K; Tobolowsky FA; Elmor R; Overton R; O'Connor SM; Damon IK; Petersen BW; Rao AK; Chatham-Stephens K; Yu P; Yu Y;
MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1190-1195. PubMed ID: 36107794
[TBL] [Abstract][Full Text] [Related]
20. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
